CURIGLIANO, GIUSEPPE

CURIGLIANO, GIUSEPPE  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 1078 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer 2026 Curigliano, GiuseppeMarra, Antonio + Article (author) -
Corrigendum to: "Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis" [Eur J Cancer 145 (2021) 197-209] 2026 Marra, AntonioMorganti, StefaniaViale, GiuliaZagami, PaolaBuccimazza, GiorgioVenetis, KonstantinosMazzarella, LucaViale, GiuseppeFusco, NicolaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Clinical characteristics and drug-drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study 2026 Curigliano, GiuseppeVernieri, Claudio + Article (author) -
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer 2026 Grasso, GDi Bisceglie, MCurigliano, GBardelli, A + Article (author) -
The role of the molecular tumor board: learnings from the ROME trial 2026 Curigliano, GBlandino, GAglietta, MCrimini, EPuglisi, FPruneri, GSavarese, ATagliaferri, PZaffignani, ETosoni, AVanella, VBotticelli, A + Article (author) -
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03 2026 Curigliano, G + Article (author) -
A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancer 2026 Boscolo Bielo, LTrapani, DZhan, YCurigliano, G + Article (author) -
Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2 2026 Curigliano, Giuseppe + Article (author) -
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale 2026 Inglese, ElviraCurigliano, GiuseppeDanesi, Romano + Article (author) -
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival 2026 Criscitiello, CCurigliano, G + Article (author) -
Impact of breast cancer on sexuality and psycho-physical wellbeing: Survey analysis 2026 Zagami, PaolaMarra, AntonioTrapani, DarioDurosini, IlariaMarsicano, RenatoMaria Berton Giachetti, Pier PaoloCurigliano, GiuseppeCriscitiello, CarmenPravettoni, Gabriella + Article (author) -
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer 2026 Curigliano, G + Article (author) -
Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens 2026 Curigliano, Giuseppe + Article (author) -
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer 2026 Trapani, DZagami, PCurigliano, G + Article (author) -
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01) 2026 Vingiani, AndreaCurigliano, Giuseppe + Article (author) -
Genomic landscape, immune microenvironment and survival in male versus female breast cancer 2026 Trapani, DCurigliano, G + Article (author) -
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer 2026 Morganti, StefaniaCurigliano, Giuseppe + Article (author) -
Impact of whole breast irradiation, endocrine therapy or their combination on outcomes of early-stage, luminal A-like, low-risk, breast cancer patients aged 65 years or over: Insights from the EUSOMA database 2026 Sardanelli, FrancescoCurigliano, Giuseppe + Article (author) -
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial 2026 Boscolo Bielo, LPietrantonio, FManca, PTortora, GSartore-Bianchi, ASiena, SCurigliano, G + Article (author) -
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025 2026 Curigliano, GiuseppeValenza, Carmine + Article (author) -